Loading...
Celularity Inc (CELU) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The stock lacks significant positive catalysts, shows weak financial performance, and has no strong trading signals or analyst support to justify immediate action. Holding off for now is recommended.
The MACD is slightly positive at 0.023, but it is contracting, indicating weakening momentum. RSI is neutral at 55.104, and moving averages are converging, showing no clear trend. Support and resistance levels suggest limited upside potential in the short term, with the pivot at 1.323 and resistance at 1.453.

NULL identified. No recent news or significant insider/hedge fund activity. The stock has a 4.7% chance of increasing in the next month, but this is not a strong indicator for long-term investment.
The stock dropped -9.46% in the regular market session, and financials show a significant YoY revenue decline (-43.16%) and gross margin drop (-64.94%). No recent congress trading data or influential figure activity. Analyst sentiment and valuation data are unavailable.
In Q3 2025, revenue dropped to $5.28M (-43.16% YoY), net income improved to -$23.08M (+43.35% YoY), and EPS increased to -0.88 (+20.55% YoY). However, gross margin fell significantly to 19 (-64.94% YoY), indicating operational inefficiencies.
No recent analyst rating or price target data available.
